1126 related articles for article (PubMed ID: 24360484)
1. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.
Gresa-Arribas N; Titulaer MJ; Torrents A; Aguilar E; McCracken L; Leypoldt F; Gleichman AJ; Balice-Gordon R; Rosenfeld MR; Lynch D; Graus F; Dalmau J
Lancet Neurol; 2014 Feb; 13(2):167-77. PubMed ID: 24360484
[TBL] [Abstract][Full Text] [Related]
2. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
Titulaer MJ; McCracken L; Gabilondo I; Armangué T; Glaser C; Iizuka T; Honig LS; Benseler SM; Kawachi I; Martinez-Hernandez E; Aguilar E; Gresa-Arribas N; Ryan-Florance N; Torrents A; Saiz A; Rosenfeld MR; Balice-Gordon R; Graus F; Dalmau J
Lancet Neurol; 2013 Feb; 12(2):157-65. PubMed ID: 23290630
[TBL] [Abstract][Full Text] [Related]
3. H-intensity scale score to estimate CSF GluN1 antibody titers with one-time immunostaining using a commercial assay.
Iizuka M; Nagata N; Kanazawa N; Iwami T; Nagashima M; Nakamura M; Kaneko J; Kitamura E; Nishiyama K; Mamorita N; Iizuka T
Front Immunol; 2024; 15():1350837. PubMed ID: 38745654
[TBL] [Abstract][Full Text] [Related]
4. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.
Petit-Pedrol M; Armangue T; Peng X; Bataller L; Cellucci T; Davis R; McCracken L; Martinez-Hernandez E; Mason WP; Kruer MC; Ritacco DG; Grisold W; Meaney BF; Alcalá C; Sillevis-Smitt P; Titulaer MJ; Balice-Gordon R; Graus F; Dalmau J
Lancet Neurol; 2014 Mar; 13(3):276-86. PubMed ID: 24462240
[TBL] [Abstract][Full Text] [Related]
5. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
Dalmau J; Gleichman AJ; Hughes EG; Rossi JE; Peng X; Lai M; Dessain SK; Rosenfeld MR; Balice-Gordon R; Lynch DR
Lancet Neurol; 2008 Dec; 7(12):1091-8. PubMed ID: 18851928
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of seronegative, but CSF antibody-positive, anti-NMDA receptor encephalitis.
Guasp M; Módena Y; Armangue T; Dalmau J; Graus F
Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31900318
[TBL] [Abstract][Full Text] [Related]
7. Anti-NMDA-receptor antibody encephalitis: performance evaluation and laboratory experience with the anti-NMDA-receptor IgG assay.
Suh-Lailam BB; Haven TR; Copple SS; Knapp D; Jaskowski TD; Tebo AE
Clin Chim Acta; 2013 Jun; 421():1-6. PubMed ID: 23454475
[TBL] [Abstract][Full Text] [Related]
8. Comparison of N-methyl-D-aspartate receptor antibody assays using live or fixed substrates.
Thouin A; Gastaldi M; Woodhall M; Jacobson L; Vincent A
J Neurol; 2021 May; 268(5):1818-1826. PubMed ID: 33389029
[TBL] [Abstract][Full Text] [Related]
9. Pitfalls in clinical diagnosis of anti-NMDA receptor encephalitis.
Kaneko A; Kaneko J; Tominaga N; Kanazawa N; Hattori K; Ugawa Y; Moriya A; Kuzume D; Ishima D; Kitamura E; Nishiyama K; Iizuka T
J Neurol; 2018 Mar; 265(3):586-596. PubMed ID: 29356973
[TBL] [Abstract][Full Text] [Related]
10. Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.
Leypoldt F; Höftberger R; Titulaer MJ; Armangue T; Gresa-Arribas N; Jahn H; Rostásy K; Schlumberger W; Meyer T; Wandinger KP; Rosenfeld MR; Graus F; Dalmau J
JAMA Neurol; 2015 Feb; 72(2):180-6. PubMed ID: 25436993
[TBL] [Abstract][Full Text] [Related]
11. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis.
Wang R; Guan HZ; Ren HT; Wang W; Hong Z; Zhou D
Seizure; 2015 Jul; 29():137-42. PubMed ID: 26076857
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients.
Jiang XY; Lei S; Zhang L; Liu X; Lin MT; Blumcke I; Piao YS; Zhou D; Li JM
Acta Neuropathol Commun; 2020 Aug; 8(1):130. PubMed ID: 32771066
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis.
Ciano-Petersen NL; Robert M; Muñiz-Castrillo S; Wucher V; Klich A; Vogrig A; Villagrán García M; Farina A; Goncalves D; Picard G; Rogemond V; Joubert B; Oliver-Martos B; Serrano-Castro PJ; Maucort-Boulch D; Honnorat J
Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37147137
[TBL] [Abstract][Full Text] [Related]
14. Fulminant course in a patient with anti-N-methyl-D-aspartate receptor encephalitis with bilateral ovarian teratomas: A case report and literature review.
Lee KW; Liou LM; Wu MN
Medicine (Baltimore); 2018 Apr; 97(15):e0339. PubMed ID: 29642173
[TBL] [Abstract][Full Text] [Related]
15. An Infant Born to a Mother With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.
Chourasia N; Watkins MW; Lankford JE; Kass JS; Kamdar A
Pediatr Neurol; 2018 Feb; 79():65-68. PubMed ID: 29310908
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor.
Hara M; Martinez-Hernandez E; Ariño H; Armangué T; Spatola M; Petit-Pedrol M; Saiz A; Rosenfeld MR; Graus F; Dalmau J
Neurology; 2018 Apr; 90(16):e1386-e1394. PubMed ID: 29549218
[TBL] [Abstract][Full Text] [Related]
17. Early operative treatment of anti-N-methyl D-aspartate (anti-NMDA) receptor encephalitis in a patient with ovarian teratoma.
Yanai S; Hashiguchi Y; Kasai M; Fukuda T; Ichimura T; Yasui T; Sumi T
Clin Exp Obstet Gynecol; 2015; 42(6):819-21. PubMed ID: 26753495
[TBL] [Abstract][Full Text] [Related]
18. Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy.
Bastiaansen AEM; de Bruijn MAAM; Schuller SL; Martinez-Hernandez E; Brenner J; Paunovic M; Crijnen YS; Mulder MJHL; Schreurs MWJ; de Graaff E; Smitt PAE; Neuteboom RF; de Vries JM; Titulaer MJ
Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 34937737
[TBL] [Abstract][Full Text] [Related]
19. Anti-NMDA Receptor Encephalitis Masquerades as Psychosis: A Case Report.
Giri YR; Korie I; Hashmi S; Parrill A; Ayed N
J Psychiatr Pract; 2022 Jan; 28(1):72-77. PubMed ID: 34989349
[TBL] [Abstract][Full Text] [Related]
20. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.
Steiner J; Walter M; Glanz W; Sarnyai Z; Bernstein HG; Vielhaber S; Kästner A; Skalej M; Jordan W; Schiltz K; Klingbeil C; Wandinger KP; Bogerts B; Stoecker W
JAMA Psychiatry; 2013 Mar; 70(3):271-8. PubMed ID: 23344076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
